CRISPR Therapeutics AG (CRSP)
After hours:
| Previous close | 55.66 |
| Open | 55.93 |
| Bid | 56.38 x 600 |
| Ask | 56.55 x 100 |
| Day's range | 55.56 - 58.67 |
| 52-week range | 37.55 - 91.10 |
| Volume | |
| Avg. volume | 1,748,433 |
| Market cap | 4.788B |
| Beta (5Y monthly) | 1.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.94 |
| Earnings date | 21 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 85.88 |
ZacksCRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why
The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $55.02, representing a -0.05% change from its previous close.
GlobeNewswireCRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
ZUG, Switzerland and BOSTON, April 22, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced an oral presentation highlighting the Company's lipid nanoparticle (LNP) approach for ocular editing will be presented at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting, taking place May 7 – 11, 2024, in Baltimore, MD and virtually. The abstract describ
Insider MonkeyCathie Wood’s Latest Stock Portfolio: Top 10 Stock Picks
In this piece, we will take a look at Cathie Wood’s latest investment portfolio and her top ten stock picks. If you want to skip our coverage of Ms. Wood, her investment firm, and the latest stock market news, then you can take a look at Cathie Wood’s Latest Stock Portfolio: Top 5 Stock Picks. […]
